Combining machine learning and structure-based approaches to develop oncogene PIM kinase inhibitors

Haifa Almukadi1, Gada Ali Jadkarim2, Arif Mohammed3

  • 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

Frontiers in Chemistry
|March 27, 2023
PubMed

Insights

Researchers developed novel PIM-1 kinase inhibitors using machine learning and structure-based methods. Four potent molecules were identified, showing promise for developing effective cancer therapeutics.

Area of Science:

  • Medicinal Chemistry
  • Computational Biology
  • Drug Discovery

Background:

  • PIM kinases are implicated in various cancers by promoting cell survival and proliferation.
  • There is a demand for potent PIM kinase inhibitors with favorable pharmacologic profiles for cancer therapy.

Purpose of the Study:

  • To generate novel and effective chemical therapeutics for PIM-1 kinase using integrated approaches.
  • To identify potent PIM-1 inhibitors with potential for cancer treatment.

Main Methods:

  • Employed machine learning (SVM, Random Forest, k-NN, XGBoost) and structure-based techniques.
  • Utilized Boruta method for descriptor selection and an ensemble approach for model development.
  • Validated potential inhibitors using molecular docking and molecular dynamics simulations.

Main Results:

  • Support Vector Machine (SVM), Random Forest, and XGBoost models demonstrated superior performance over k-NN.
  • Identified four potential PIM-1 modulating molecules: CHEMBL303779, CHEMBL690270, MHC07198, and CHEMBL748285.
  • Molecular dynamics simulations confirmed the stability of protein-ligand interactions for the identified molecules.

Conclusions:

  • The developed machine learning models are robust and effective for PIM kinase inhibitor discovery.
  • The identified molecules hold potential for the development of novel PIM kinase inhibitors against human cancers.